Drug Details
General Information of the Drug (ID: DR1126) | ||||
---|---|---|---|---|
Name |
Risedronate
|
|||
Synonyms |
Risedronic acid; Risedronate; 105462-24-6; Atelvia; Risedronic acid monohydrate; Benet; NE-58095; UNII-KM2Z91756Z; (1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid; Phosphonic acid, [1-hydroxy-2-(3-pyridinyl)ethylidene]bis-; (1-hydroxy-1-phosphono-2-pyridin-3-yl-ethyl)phosphonic acid; Risedronic acid (Actonel); CHEMBL923; CHEBI:8869; Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-; [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonic acid; 1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE BIS-PHOSPHONIC ACID; KM2Z91756Z; RIS; (1-hydroxy-2-pyridin-3-ylethane-1,1-diyl)bis(phosphonic acid); Acido risedronico; Acide risedronique; Acidum risedronicum; Risedronic acid [INN:BAN]; (1-hydroxy-2-(pyridin-3-yl)ethane-1,1-diyl)bis(phosphonic acid); Acide risedronique [INN-French]; Acido risedronico [INN-Spanish]; Acidum risedronicum [INN-Latin]; 115436-72-1; Bisphosphonate 1; C7H11NO7P2.H2O; [1-hydroxy-1-phosphono-2-(3-pyridyl)ethyl]phosphonic acid; Ridron (TN); C7H11NO7P2; MFCD00867080; NE 58019; HSDB 7326; Risedronic acid (INN); 1-Hydroxy-2-(3-pyridyl)-ethan-1,1-bis-phosphonic acid; Risdronate; Risedronate acid; SR-05000001495; M05BA07; (1-Hydroxy-2-(3-pyridyl)ethylidene)diphosphonic acid; PubChem14002; SCHEMBL18378; BIDD:GT0010; GTPL3176; JMC515594 Compound 64; DTXSID2023563; BDBM12576; AMY3524; HMS2090C21; HMS3741A17; BCP13805; HY-B0148; ZINC1531009; 2689AH; s1874; AKOS015892564; AC-1295; CS-1964; DB00884; NCGC00386377-01; AS-13584; I802; AB0013898; FT-0642593; A11675; C08233; D08484; M-1366; AB01275490-01; AB01275490_02; 462R246; A801245; Q408724; SR-05000001495-1; 2-(3-pyridyl)-1-hydroxyethane-1,1-bisphosphonic acid; Z2684418685; (1-Hydroxy-2-(pyridin-3-yl)ethane-1,1-diyl)diphosphonic acid; (1-oxidanyl-1-phosphono-2-pyridin-3-yl-ethyl)phosphonic acid; [1-hydroxy-1-phosphono-2-(3-pyridinyl)ethyl]phosphonic acid; 1-hydroxy-2-(pyridin-3-yl)ethane-1,1-diyldiphosphonic acid
Click to Show/Hide
|
|||
Molecular Type |
Small molecule
|
|||
Disease | Bone paget disease [ICD-11: FB85] | Approved | [1] | |
Structure |
![]() |
Click to Download Mol2D MOL |
||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | ||||
Formula |
C7H11NO7P2
|
|||
PubChem CID | ||||
Canonical SMILES |
C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
|
|||
InChI |
1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)
|
|||
InChIKey |
IIDJRNMFWXDHID-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 105462-24-6
|
|||
ChEBI ID | ||||
TTD Drug ID | ||||
DrugBank ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Natural Product(s) Able to Decrease the Adverse Effect of This Drug | ||||||
Glucosamine | Homo sapiens | Click to Show/Hide the Molecular Data of This NP | ||||
Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
In-vivo Model | Rabbits quarantine OA was induced by anterior cruciate ligament transection (ACLT) and partial medial meniscectomy on one knee. | |||||
Experimental
Result(s) |
Glucosamine sulfate and risedronate treatment alone or in combination may be able to stop cartilage swelling. The risedronate treatment could partially stop the fibrillation and the inflammation of synovial membrane as well as modify the orientation of trabeculae in healthy and in osteoarthritic knees. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Geranyltranstransferase (FDPS) | Molecule Info | [3] | |
BioCyc | Superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) | Click to Show/Hide | ||
2 | Superpathway of cholesterol biosynthesis | |||
3 | Trans, trans-farnesyl diphosphate biosynthesis | |||
4 | Geranylgeranyldiphosphate biosynthesis | |||
KEGG Pathway | Terpenoid backbone biosynthesis | Click to Show/Hide | ||
2 | Metabolic pathways | |||
3 | Biosynthesis of antibiotics | |||
4 | Influenza A | |||
5 | HTLV-I infection | |||
NetPath Pathway | TCR Signaling Pathway | Click to Show/Hide | ||
Panther Pathway | Cholesterol biosynthesis | Click to Show/Hide | ||
Pathwhiz Pathway | Steroid Biosynthesis | Click to Show/Hide | ||
Reactome | Cholesterol biosynthesis | Click to Show/Hide | ||
2 | Activation of gene expression by SREBF (SREBP) | |||
WikiPathways | Activation of Gene Expression by SREBP (SREBF) | Click to Show/Hide | ||
2 | SREBP signalling | |||
3 | Cholesterol Biosynthesis |
